Journey Medical Corp. (DERM) NASDAQ
$3.58 (0.28) (-7.25%)
Market Cap: $53.78M
As of 04/18/24 04:00 PM EDT. Market closed.
Journey Medical Corp. (DERM)
NASDAQ
$3.58
(0.28) (-7.25%)
Market Cap: $53.78M
As of 04/18/24 04:00 PM EDT. Market closed.
Add to Portfolio
COMPANY PROFILE
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
URL
Address
.
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
CEO Compensation (Base)
$572,500
URL
Address
.
PRICE CHART FOR JOURNEY MEDICAL CORP
From:
To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$3.80
Previous Close
$3.86
Days Range
$3.51 - $3.86
52 week range
$1.02 - $8.11
Volume
189,103
Avg. Volume (30 days)
232,115
Market Cap
$53.78M
Dividend Yield
-
P/E
(13.96)
Shares Outstanding
13,932,310
Open
$3.80
Previous Close
$3.86
Days Range
$3.51 - $3.86
52 week range
$1.02 - $8.11
Volume
189,103
Avg. Volume (30 days)
232,115
Market Cap
$53.78M
Dividend Yield
-
P/E
(13.96)
Shares Outstanding
13,932,310
FINANCIAL STATEMENTS FOR JOURNEY MEDICAL CORP
LOADING...
Open in: 
Open in:
INSIDER TRANSACTIONS FOR JOURNEY MEDICAL CORP
| Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
| ROSENWALD LINDSAY A MD | Director | Mar 25, 2024 | Buy | $3.04 | 10,000 | 30,400 | 144,245 | Mar 27, 2024, 07:00 AM |
| Maraoui Claude | President & CEO | Mar 22, 2024 | Buy | $3.48 | 10,000 | 34,790 | 2,163,430 | Mar 25, 2024, 04:03 PM |
| Smith Justin Adam | Director | Mar 22, 2024 | Buy | $3.47 | 30,000 | 104,100 | 134,717 | Mar 25, 2024, 04:02 PM |
| ROSENWALD LINDSAY A MD | Director | Mar 22, 2024 | Buy | $3.40 | 20,000 | 68,000 | 134,245 | Mar 25, 2024, 04:01 PM |
| Benesch Joseph | Interim CFO | Feb 22, 2024 | Sale | $3.75 | 2,450 | 9,188 | 60,710 | Feb 23, 2024, 05:54 PM |
| Paley Jeffrey | Director | Nov 08, 2023 | Sale | $3.76 | 255 | 959 | 114,217 | Dec 08, 2023, 05:01 PM |
| Paley Jeffrey | Director | Nov 07, 2023 | Sale | $3.48 | 2,245 | 7,813 | 114,472 | Dec 08, 2023, 05:01 PM |
| Paley Jeffrey | Director | Nov 28, 2023 | Sale | $5.22 | 1,745 | 9,109 | 70,727 | Nov 29, 2023, 04:42 PM |
| Smith Justin Adam | Director | Oct 13, 2023 | Buy | $2.98 | 33,000 | 98,340 | 104,717 | Oct 17, 2023, 04:01 PM |
| Paley Jeffrey | Director | Oct 06, 2023 | Buy | $2.98 | 15,000 | 44,700 | 72,472 | Oct 10, 2023, 04:41 PM |
| Paley Jeffrey | Director | Sep 21, 2023 | Buy | $2.97 | 30,000 | 89,100 | 57,472 | Sep 25, 2023, 04:01 PM |
| Maraoui Claude | President & CEO | Sep 06, 2023 | Buy | $2.52 | 26,044 | 65,631 | 2,153,430 | Sep 08, 2023, 01:26 PM |
| ROSENWALD LINDSAY A MD | Director | Sep 06, 2023 | Buy | $2.23 | 100,000 | 223,000 | 114,245 | Sep 08, 2023, 01:25 PM |
| Maraoui Claude | President & CEO | Jul 24, 2023 | Sale | $1.76 | 20,767 | 36,550 | 2,127,386 | Jul 25, 2023, 04:05 PM |
| Benesch Joseph | See Remarks | Jul 24, 2023 | Sale | $1.76 | 4,072 | 7,167 | 63,160 | Jul 25, 2023, 04:05 PM |
| Maraoui Claude | President & CEO | May 17, 2023 | Sale | $1.34 | 24,377 | 32,665 | 2,148,153 | May 18, 2023, 04:31 PM |
| Maraoui Claude | President & CEO | May 16, 2023 | Sale | $1.25 | 20,000 | 25,000 | 2,172,530 | May 18, 2023, 04:31 PM |
| De Paolantonio Ernest Robert | See Remarks | Oct 04, 2022 | Sale | $2.41 | 10,093 | 24,324 | 259,907 | Mar 01, 2023, 09:46 PM |
| Benesch Joseph | Interim CFO | Feb 22, 2023 | Sale | $1.97 | 2,768 | 5,453 | 67,232 | Feb 23, 2023, 05:01 PM |
| De Paolantonio Ernest Robert | Chief Financial Officer | Oct 04, 2022 | Sale | $2.41 | 10,093 | 24,324 | 259,907 | Oct 06, 2022, 04:30 PM |
Load More Insider Transactions
Buy
Sale
Option Exercise
| Owner | Relationship | Date | Value($) |
| ROSENWALD LINDSAY A MD | Director | 03/25/2024 | 30,400 |
| Maraoui Claude | President & CEO | 03/22/2024 | 34,790 |
| Smith Justin Adam | Director | 03/22/2024 | 104,100 |
| ROSENWALD LINDSAY A MD | Director | 03/22/2024 | 68,000 |
| Benesch Joseph | Interim CFO | 02/22/2024 | 9,188 |
| Paley Jeffrey | Director | 11/08/2023 | 959 |
| Paley Jeffrey | Director | 11/07/2023 | 7,813 |
| Paley Jeffrey | Director | 11/28/2023 | 9,109 |
| Smith Justin Adam | Director | 10/13/2023 | 98,340 |
| Paley Jeffrey | Director | 10/06/2023 | 44,700 |
| Paley Jeffrey | Director | 09/21/2023 | 89,100 |
| Maraoui Claude | President & CEO | 09/06/2023 | 65,631 |
| ROSENWALD LINDSAY A MD | Director | 09/06/2023 | 223,000 |
| Maraoui Claude | President & CEO | 07/24/2023 | 36,550 |
| Benesch Joseph | See Remarks | 07/24/2023 | 7,167 |
| Maraoui Claude | President & CEO | 05/17/2023 | 32,665 |
| Maraoui Claude | President & CEO | 05/16/2023 | 25,000 |
| De Paolantonio Ernest Robert | See Remarks | 10/04/2022 | 24,324 |
| Benesch Joseph | Interim CFO | 02/22/2023 | 5,453 |
| De Paolantonio Ernest Robert | Chief Financial Officer | 10/04/2022 | 24,324 |
Load More Insider Transactions
FUNDS WITH A POSITION IN JOURNEY MEDICAL CORP
| Fund | # Shares Owned | % of Portfolio | % Change | Investing Style |
|---|---|---|---|---|
| RENAISSANCE TECHNOLOGIES LLC | 261,000 | 0.00233% | 1148.8% | Other |
| GEODE CAPITAL MANAGEMENT, LLC | 85,785 | 0.00005% | 23.42% | Other |
| BLACKROCK INC. | 43,892 | 0.00001% | 204.97% | Other |
CHANGE IN SHARES OUTSTANDING FOR JOURNEY MEDICAL CORP
STOCK BUYBACKS FOR JOURNEY MEDICAL CORP
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
Load More
Period of Report: 12/31/2023
10-K/10-Q Filings: View
Previous Period
% Change in Shares
Quarter
09/30/2023
-11.13%
1Q
06/30/2023
3.83%
2Q
03/31/2023
4.98%
3Q
12/31/2022
5.43%
4Q
09/30/2022
6.11%
5Q
06/30/2022
7.09%
6Q
03/31/2022
7.95%
7Q
12/31/2021
83.46%
8Q
03/31/2021
71.55%
11Q
12/31/2020
71.64%
12Q
09/30/2020
73.09%
13Q
06/30/2020
72.57%
14Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR JOURNEY MEDICAL CORP
LOADING...